Central Nervous System (CNS) therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... mation on the therapeutics under development for Childhood Epilepsy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharm......" | 30-Apr-2021 | $2000 | |
Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... omprehensive information on the therapeutics under development for Acute Spinal Cord Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also cove......" | 30-Apr-2021 | $2000 | |
Epileptic Encephalopathy (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... omprehensive information on the therapeutics under development for Epileptic Encephalopathy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also cove......" | 30-Apr-2021 | $2000 | |
Peripheral Nerve Injury (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... rehensive information on the therapeutics under development for Peripheral Nerve Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers t......" | 30-Apr-2021 | $2000 | |
Brain Hemorrhage (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Brain Hemorrhage, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacologic......" | 30-Apr-2021 | $2000 | |
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... vere Myoclonic Epilepsy of Infancy) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy), complete with analysis by Stage of De......" | 30-Apr-2021 | $2000 | |
Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... ion on the therapeutics under development for Anxiety Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacol......" | 30-Apr-2021 | $2000 | |
Dental Pain (Toothache/Tooth Pain) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... >
The report provides comprehensive information on the therapeutics under development for Dental Pain (Toothache/Tooth Pain), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA)......" | 30-Apr-2021 | $2000 | |
Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... >
The report provides comprehensive information on the therapeutics under development for Generalized Anxiety Disorder (GAD), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA)......" | 30-Apr-2021 | $2000 | |
Infantile Spasm (West Syndrome) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... The report provides comprehensive information on the therapeutics under development for Infantile Spasm (West Syndrome), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecul......" | 30-Apr-2021 | $2000 | |
|